Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Elewaut

Showing results (51-60 of 299) with videos related to

Pageof 30
Sort By:
Nature Medicine|February 16, 2024
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trialRuth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, et al.
Biochemical Pharmacology|April 13, 2019
Risks and benefits of corticosteroids in arthritic diseases in the clinicIoanna Petta, Isabelle Peene, Dirk Elewaut, et al.
Methods in Molecular Medicine|July 29, 2004
Analysis of chondrocyte functional markers and pericellular matrix components by flow cytometryGust Verbruggen, Jun Wang, Lai Wang, et al.
Current Opinion in Rheumatology|January 15, 2015
Integrating the pathogenesis of spondyloarthritis: gut and joint united?Katelijne De Wilde, Karlijn Debusschere, Sam Beeckman, et al.
Arthritis Research & Therapy|June 12, 2013
Microbes, the gut and ankylosing spondylitisMary-Ellen Costello, Dirk Elewaut, Tony J Kenna, et al.
Nature Reviews. Rheumatology|April 18, 2012
The transition of acute to chronic bowel inflammation in spondyloarthritisLiesbet Van Praet, Peggy Jacques, Filip Van den Bosch, et al.
Current Rheumatology Reports|July 12, 2011
Mucosal inflammation in spondylarthritides: past, present, and futureLiesbet Van Praet, Filip Van den Bosch, Herman Mielants, et al.
Frontiers in Genetics|July 22, 2021
From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory DiseasesDominika Hromadová, Dirk Elewaut, Robert D Inman, et al.
Allergy|July 19, 2022
Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?Oscar Palomares, Dirk Elewaut, Peter M Irving, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed jointsLode Melis, Liesbet Van Praet, Hanspeter Pircher, et al.
Pageof 30

Showing results (51-60 of 299) with videos related to

Sort By:
Pageof 30
Nature Medicine|February 16, 2024
RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trialRuth Wittoek, Gust Verbruggen, Tine Vanhaverbeke, et al.
Biochemical Pharmacology|April 13, 2019
Risks and benefits of corticosteroids in arthritic diseases in the clinicIoanna Petta, Isabelle Peene, Dirk Elewaut, et al.
Methods in Molecular Medicine|July 29, 2004
Analysis of chondrocyte functional markers and pericellular matrix components by flow cytometryGust Verbruggen, Jun Wang, Lai Wang, et al.
Current Opinion in Rheumatology|January 15, 2015
Integrating the pathogenesis of spondyloarthritis: gut and joint united?Katelijne De Wilde, Karlijn Debusschere, Sam Beeckman, et al.
Arthritis Research & Therapy|June 12, 2013
Microbes, the gut and ankylosing spondylitisMary-Ellen Costello, Dirk Elewaut, Tony J Kenna, et al.
Nature Reviews. Rheumatology|April 18, 2012
The transition of acute to chronic bowel inflammation in spondyloarthritisLiesbet Van Praet, Peggy Jacques, Filip Van den Bosch, et al.
Current Rheumatology Reports|July 12, 2011
Mucosal inflammation in spondylarthritides: past, present, and futureLiesbet Van Praet, Filip Van den Bosch, Herman Mielants, et al.
Frontiers in Genetics|July 22, 2021
From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory DiseasesDominika Hromadová, Dirk Elewaut, Robert D Inman, et al.
Allergy|July 19, 2022
Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?Oscar Palomares, Dirk Elewaut, Peter M Irving, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed jointsLode Melis, Liesbet Van Praet, Hanspeter Pircher, et al.
Pageof 30